PALB2 and cancer: No statistically significant difference was found between the distribution of the PALB2 P/LP mutation types regarding frameshift, stop, and missense variants in our samples compared to cases of the gnomAD non-cancer database, where the frameshift, stop, splice, and missense variant frequencies were 66.8%, 30.7%, 2.4%, and 0%, respectively (Table 5).